Literature DB >> 22330646

Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection.

Crystal H Johnson1, Congrong Miao, Elisabeth G Blanchard, Hayat Caidi, Gertrud U Radu, Jennifer L Harcourt, Lia M Haynes.   

Abstract

Respiratory syncytial virus (RSV) is the most common cause of serious lower respiratory illness in infants and young children worldwide, making it a high priority for development of strategies for prevention and treatment. RSV can cause repeat infections throughout life, with serious complications in elderly and immunocompromised patients. Previous studies indicate that the RSV G protein binds through a CX3C chemokine motif to the host chemokine receptor, CX3CR1, and modulates the inflammatory immune response. In the current study, we examined the contribution of CX3CR1 to the immune response to RSV infection in mice. CX3CR1-deficient mice showed an impaired innate immune response to RSV infection, characterized by substantially decreased NK1.1(+) natural killer, CD11b(+), and RB6-8C5(+) polymorphonuclear cell trafficking to the lung and reduced IFNγ production compared with those in wildtype control mice. Leukocytes from CX3CR1-deficient mice were poorly chemotactic toward RSV G protein and CX3CL1. These results substantiate the importance of the RSV G CX3C-CX3CR1 interaction in the innate immune response to RSV infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22330646      PMCID: PMC3276387     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  28 in total

1.  Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P.

Authors:  Lia M Haynes; Les P Jones; Albert Barskey; Larry J Anderson; Ralph A Tripp
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

2.  Analyses of phenotypic and functional characteristics of CX3CR1-expressing natural killer cells.

Authors:  Isabell Hamann; Nadine Unterwalder; Astrid E Cardona; Christian Meisel; Frauke Zipp; Richard M Ransohoff; Carmen Infante-Duarte
Journal:  Immunology       Date:  2011-02-14       Impact factor: 7.397

3.  Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion.

Authors:  S Jung; J Aliberti; P Graemmel; M J Sunshine; G W Kreutzberg; A Sher; D R Littman
Journal:  Mol Cell Biol       Date:  2000-06       Impact factor: 4.272

4.  CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein.

Authors:  R A Tripp; L P Jones; L M Haynes; H Zheng; P M Murphy; L J Anderson
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

5.  Respiratory syncytial virus infection in inbred mice.

Authors:  G A Prince; R L Horswood; J Berndt; S C Suffin; R M Chanock
Journal:  Infect Immun       Date:  1979-11       Impact factor: 3.441

6.  Genetic susceptibility to respiratory syncytial virus infection in inbred mice.

Authors:  James M Stark; Susan A McDowell; Vincent Koenigsknecht; Daniel R Prows; John E Leikauf; Ann Marie Le Vine; George D Leikauf
Journal:  J Med Virol       Date:  2002-05       Impact factor: 2.327

7.  Fractalkine-mediated endothelial cell injury by NK cells.

Authors:  O Yoneda; T Imai; S Goda; H Inoue; A Yamauchi; T Okazaki; H Imai; O Yoshie; E T Bloom; N Domae; H Umehara
Journal:  J Immunol       Date:  2000-04-15       Impact factor: 5.422

8.  Fractalkine receptor expression by T lymphocyte subpopulations and in vivo production of fractalkine in human.

Authors:  A Foussat; A Coulomb-L'Hermine; J Gosling; R Krzysiek; I Durand-Gasselin; T Schall; A Balian; Y Richard; P Galanaud; D Emilie
Journal:  Eur J Immunol       Date:  2000-01       Impact factor: 5.532

Review 9.  Pathogenesis of respiratory syncytial virus infection.

Authors:  Ralph A Tripp
Journal:  Viral Immunol       Date:  2004       Impact factor: 2.257

10.  Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression.

Authors:  Miyuki Nishimura; Hisanori Umehara; Takashi Nakayama; Osamu Yoneda; Kunio Hieshima; Mayumi Kakizaki; Naochika Dohmae; Osamu Yoshie; Toshio Imai
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

View more
  13 in total

1.  Respiratory syncytial virus infection of newborn CX3CR1-deficient mice induces a pathogenic pulmonary innate immune response.

Authors:  Sudipta Das; Mahesh Raundhal; Jie Chen; Timothy B Oriss; Rachael Huff; John V Williams; Anuradha Ray; Prabir Ray
Journal:  JCI Insight       Date:  2017-09-07

2.  Monocytes in sterile inflammation: recruitment and functional consequences.

Authors:  Jessica H Spahn; Daniel Kreisel
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-12-06       Impact factor: 4.291

Review 3.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

4.  The chemokine CX3CL1/fractalkine regulates immunopathogenesis during fungal-associated allergic airway inflammation.

Authors:  Matthew S Godwin; MaryJane Jones; Jonathan P Blackburn; Zhihong Yu; Sadis Matalon; Annette T Hastie; Deborah A Meyers; Chad Steele
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-12-16       Impact factor: 5.464

Review 5.  Modulation of the host immune response by respiratory syncytial virus proteins.

Authors:  Megan E Schmidt; Steven M Varga
Journal:  J Microbiol       Date:  2017-02-28       Impact factor: 2.902

6.  Meta-Analysis of Whole Blood Transcriptome Datasets Characterizes the Immune Response of Respiratory Syncytial Virus Infection in Children.

Authors:  Qianyu Feng; Shujin Lin; Huifang Liu; Bin Yang; Lifen Han; Xiao Han; Lili Xu; Zhengde Xie
Journal:  Front Cell Infect Microbiol       Date:  2022-04-13       Impact factor: 6.073

Review 7.  Modulation of host adaptive immunity by hRSV proteins.

Authors:  Janyra A Espinoza; Karen Bohmwald; Pablo F Céspedes; Claudia A Riedel; Susan M Bueno; Alexis M Kalergis
Journal:  Virulence       Date:  2014       Impact factor: 5.882

Review 8.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

9.  CX3CR1 Is a Receptor for Human Respiratory Syncytial Virus in Cotton Rats.

Authors:  Gia Green; Sara M Johnson; Heather Costello; Kelsey Brakel; Olivia Harder; Antonius G Oomens; Mark E Peeples; Hong M Moulton; Stefan Niewiesk
Journal:  J Virol       Date:  2021-07-26       Impact factor: 5.103

10.  Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures.

Authors:  Sara M Johnson; Beth A McNally; Ioannis Ioannidis; Emilio Flano; Michael N Teng; Antonius G Oomens; Edward E Walsh; Mark E Peeples
Journal:  PLoS Pathog       Date:  2015-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.